Výsledky vyhledávání - "T. D. Zhuchenko"

[Levitra in the treatment of patients with chronic prostatitis associated with sexual dysfunction]

Autor: Iu M, Esilevskiĭ, Iu G, Aliaev, G E, Krupinov, T D, Zhuchenko, N D, Akhvlediani

Publikováno v: Urologiia (Moscow, Russia : 1999). (6)

Sixty patients with chronic prostatitis and sexual dysfunction were divided into two groups. All the patients received one-month standard course of physiotherapy. In addition, group I (n = 30) was given levitra (vardenafil; 5 mg per os each other day

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1873fa1683066b88ea598a74ddcae67f
https://pubmed.ncbi.nlm.nih.gov/17315706

Zobrazit plný text záznamu

[Systemic approach to investigation of levitra efficacy in patients with chronic prostatitis with erectile dysfunction]

Autor: Iu G, Aliaev, M A, Ronkin, Iu M, Esilevskiĭ, T D, Zhuchenko, Iu L, Demidko, G E, Krupinov, V Iu, Shcherbanina

Publikováno v: Urologiia (Moscow, Russia : 1999). (2)

Ultrasonic dopplerography of prostatic, scrotal and penile vessels before and after intake of levitra in a dose 10 mg was made in 22 patients with chronic abacterial prostatitis in combination with erectile dysfunction and after their combined levitr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dd6da989c94a693b2b1b625d5691ddb7
https://pubmed.ncbi.nlm.nih.gov/15989030

Zobrazit plný text záznamu

[Use of glatiramer acetate (Copaxone) in the treatment of patients with multiple sclerosis. Experience of the Moscow multiple sclerosis center]

Autor: T L, Demina, M V, Davydovskaia, N Iu, Lashch, N F, Popova, N V, Khachanova, T D, Zhuchenko

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (Spec No 2)

146 patients with multiple sclerosis are treated by copaxone in the Moscow MS Centre. The relaps exacerbation rate decreased by 72%, the relapse rate reduced by 25.6% during the copaxone treatment. EDSS score did not increase both in group with and w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::994fbe4c7ff85fd69bb43801484e49ef
https://pubmed.ncbi.nlm.nih.gov/12938642

Zobrazit plný text záznamu

[Glatiramer acetate (Copaxone) influence on different stages of multiple sclerosis pathogenesis]

Autor: T E, Shmidt, T D, Zhuchenko, N N, Iakhno

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. (Spec No 2)

Multiple sclerosis (MS)--autoimmune disease of CNS, characterized by myelin destruction and axonal damage. The action of drugs recommended for its treatment [symbol: see text] aimy[symbol: see text] at the reduction of the autoimmune responses. These

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::475c65eb22fdd7a7267e12a693d7db6e
https://pubmed.ncbi.nlm.nih.gov/12938640

Zobrazit plný text záznamu

Clinico-stabilographic investigation of eduilibrium disorders in patients of elderly age with chronic vascular cerebral deficiency

Autor: N. N. Yakhno, T. D. Zhuchenko, V. A. Podorolsky, I. V. Damulin

Publikováno v: Neurology Bulletin. :20-22

As many as 50 patients aged over 60 years suffering from chronic vascular cerebral deficiency with equilibrium disorders are examined. The neurological- ly sharply defined symptomocomplexes explaining the equilibrium disorders and having stabilograph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::30a3e71c98a6c7161e2c6ab4c435af11
https://doi.org/10.17816/nb106625

Zobrazit plný text záznamu

[Mechanisms of glatiramer acetate action in demyelinating diseases: antigen-specific, organ-specific or process-specific treatment]

Autor: A N, Boĭko, T D, Zhuchenko, E I, Gusev

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Use of the "disease modifying" medicines is a significant success in multiple sclerosis (MS) treatment. These ways of MS treatment were scientificantly based and proved in large well-designed randomized studies, while direct mechanisms of their actio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e573d0dddb99a16aa146206e7ec8d93d
https://pubmed.ncbi.nlm.nih.gov/12418393

Zobrazit plný text záznamu

[Results of open post-registration clinical trials of copaxone in patients with multiple sclerosis]

Autor: I A, Zavalishin, E I, Gusev, N N, Iakhno, M A, Ronkin, T E, Shmidt, T L, Demina, A I, Kugoev, L S, Adarcheva, A S, Niiazbekova, M N, Zakharova, A B, Peresedova, G G, Toropina, L A, Klishevskaia, I M, Maksimenko, M V, Krotenkova, S N, Konovalov, O Iu, Rebrova, T D, Zhuchenko

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

Results of the 2-year open postregistration study of Copaxone (glatiramer acetate), conducted in 3 Moscow leading medical centres are given. 32 MS patients with remitting-relapsing MS were investigated in accordance with international requirements (n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::29dbd2cb5509dc12ab0dd7399c648f7b
https://pubmed.ncbi.nlm.nih.gov/12418394

Zobrazit plný text záznamu

[Pathogenesis and treatment of multiple sclerosis (state of the art in 2000)]

Autor: I A, Zavalishin, T D, Zhuchenko, A V, Peresedova

Publikováno v: Vestnik Rossiiskoi akademii meditsinskikh nauk. (7)

Multiple sclerosis is universally accepted to be a multifactorial disease whose pathogenesis is due to a complex of immunopathological and pathochemical reactions. The key assumption is that only early stages of immunopathological chain reactions inv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d54116cc13aeb64cc7bbbe0c50747f73
https://pubmed.ncbi.nlm.nih.gov/11523422

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání